Clearside Biomedical Inc. (CLSD)
NASDAQ: CLSD
· Real-Time Price · USD
0.50
-0.04 (-7.20%)
At close: Jul 25, 2025, 3:59 PM
Clearside Biomedical Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -8.22M | -7.31M | -7.69M | -7.59M | -11.76M | -4.83M | -9.27M | -9.11M | -9.28M | -9.66M | -7.83M | -7.81M | -7.64M | 18.71M | -4.89M | -6.09M | -7.35M |
Depreciation & Amortization | 85K | 79K | 75K | 44K | 28K | 20K | 16K | 16K | 15K | 22K | 39K | 38K | 46K | 45K | 44K | 44K | 45K |
Stock-Based Compensation | 721K | 1.17M | 1.17M | 1.12M | 1.06M | 1.03M | 1.07M | 1.06M | 1.04M | 1.15M | 1.07M | 1.35M | 1.31M | 1.25M | 1.32M | 1.33M | 1.15M |
Other Working Capital | n/a | 656K | -1.35M | 437K | 30K | 1.36M | -1.27M | 114K | -1.16M | 160.58K | 70K | -453K | 10.85M | -5.04M | 249K | -2.23M | 243K |
Other Non-Cash Items | n/a | 461K | 1.92M | 313K | 6.13M | 2.7M | 2.62M | 2.29M | 2.17M | 2.02M | 1.1M | -1K | n/a | -15.34M | n/a | n/a | -998K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | -419K | n/a | n/a | n/a | n/a | n/a | 1K | n/a | 15.34M | n/a | n/a | n/a |
Change in Working Capital | n/a | 346K | -1.38M | 437K | -1.08M | 2M | -520K | 396K | -1.16M | 865K | -769K | 978K | 10.16M | -14.95M | 249K | -2.23M | 1.59M |
Operating Cash Flow | -5.83M | -5.25M | -5.91M | -5.68M | -7.85M | 495K | -6.08M | -5.34M | -7.22M | -5.61M | -6.19M | -5.44M | 3.87M | 5.05M | -3.28M | -6.95M | -5.56M |
Capital Expenditures | n/a | -444K | -53K | -423K | -57K | -120K | -445K | -1.1M | -115K | -91K | -155K | n/a | n/a | n/a | n/a | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | 1K | -5.9M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | 9.75M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | -9K | n/a | 7.5M | -11.01M | -220K | -2.31M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | -9K | 9.31M | 1.55M | -11.44M | -57K | -120K | -445K | -1.1M | -115K | -91K | -155K | n/a | n/a | n/a | n/a | n/a | n/a |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | -21K | 21K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -553K | n/a | 14K | n/a | 33K | -1M | 51K | -340K | 37K | 9K | 30.69M | 4K | 65K | 165K | 206K | 33K | 92K |
Financial Cash Flow | -553K | 2.08M | 14K | n/a | 14.34M | -257K | 317K | 22K | 332K | 575K | 30.69M | 4K | 65K | 165K | 2.08M | 7.12M | 14.42M |
Net Cash Flow | -6.39M | 6.13M | -4.35M | -17.12M | 6.43M | 118K | -6.2M | -6.41M | -7M | -5.12M | 24.35M | -5.44M | 3.94M | 5.22M | -1.2M | 167K | 8.86M |
Free Cash Flow | -5.83M | -5.7M | -5.97M | -6.1M | -7.91M | 375K | -6.52M | -6.44M | -7.33M | -5.7M | -6.34M | -5.44M | 3.87M | 5.05M | -3.28M | -6.95M | -5.56M |